| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Anticipating designer drug-resistant cancer cells
|
Frangione, Mark L.
|
|
2015
|
20 |
7 |
p. 790-793
4 p.
|
artikel
|
| 2 |
Biopharma CRO industry in China: landscape and opportunities
|
Xia, Christine
|
|
2015
|
20 |
7 |
p. 794-798
5 p.
|
artikel
|
| 3 |
Bispecific antibodies
|
Kontermann, Roland E.
|
|
2015
|
20 |
7 |
p. 838-847
10 p.
|
artikel
|
| 4 |
Contents page 1
|
|
|
2015
|
20 |
7 |
p. i-
1 p.
|
artikel
|
| 5 |
Contents page 2
|
|
|
2015
|
20 |
7 |
p. iii-
1 p.
|
artikel
|
| 6 |
Crowdsourcing in pharma: a strategic framework
|
Bentzien, Jörg
|
|
2015
|
20 |
7 |
p. 874-883
10 p.
|
artikel
|
| 7 |
Cruzain inhibitors: efforts made, current leads and a structural outlook of new hits
|
Martinez-Mayorga, Karina
|
|
2015
|
20 |
7 |
p. 890-898
9 p.
|
artikel
|
| 8 |
Epigenetic mechanisms in heart development and disease
|
Martinez, Shannalee R.
|
|
2015
|
20 |
7 |
p. 799-811
13 p.
|
artikel
|
| 9 |
Key challenges in the treatment of rare pediatric skeletal genetic disorders: from bench to bedside
|
Lorget, Florence
|
|
2015
|
20 |
7 |
p. 781-783
3 p.
|
artikel
|
| 10 |
Molecular basis for nonspecificity of nonsteroidal anti-inflammatory drugs (NSAIDs)
|
Dwivedi, Avaneesh K.
|
|
2015
|
20 |
7 |
p. 863-873
11 p.
|
artikel
|
| 11 |
Nanoparticle technology for treatment of Parkinson's disease: the role of surface phenomena in reaching the brain
|
Leyva-Gómez, Gerardo
|
|
2015
|
20 |
7 |
p. 824-837
14 p.
|
artikel
|
| 12 |
Pathophysiologically relevant in vitro tumor models for drug screening
|
Das, Viswanath
|
|
2015
|
20 |
7 |
p. 848-855
8 p.
|
artikel
|
| 13 |
Polymeric formulations for drug release prepared by hot melt extrusion: application and characterization
|
Stanković, Milica
|
|
2015
|
20 |
7 |
p. 812-823
12 p.
|
artikel
|
| 14 |
Pragmatic randomized trials in drug development pose new ethical questions: a systematic review
|
Kalkman, Shona
|
|
2015
|
20 |
7 |
p. 856-862
7 p.
|
artikel
|
| 15 |
Punctal plug: a medical device to treat dry eye syndrome and for sustained drug delivery to the eye
|
Yellepeddi, Venkata K.
|
|
2015
|
20 |
7 |
p. 884-889
6 p.
|
artikel
|
| 16 |
Target selection for FDA-approved medicines
|
Kinch, Michael S.
|
|
2015
|
20 |
7 |
p. 784-789
6 p.
|
artikel
|
| 17 |
Toward an effective strategy in glioblastoma treatment. Part I: resistance mechanisms and strategies to overcome resistance of glioblastoma to temozolomide
|
Messaoudi, Khaled
|
|
2015
|
20 |
7 |
p. 899-905
7 p.
|
artikel
|
| 18 |
Urocortin 2 in cardiovascular health and disease
|
Adão, Rui
|
|
2015
|
20 |
7 |
p. 906-914
9 p.
|
artikel
|
Tijdschrift beschrijving